{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:45:00Z","timestamp":1789177500007,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R34 MH120106"],"award-info":[{"award-number":["R34 MH120106"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K99 MH121166"],"award-info":[{"award-number":["K99 MH121166"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30 AI027757"],"award-info":[{"award-number":["P30 AI027757"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Introduction<\/jats:title>\n<jats:p>In Kenya, pre-exposure prophylaxis (PrEP) for HIV prevention is almost exclusively delivered at HIV clinics. Developing novel PrEP delivery models is important for increasing the reach of PrEP. Delivery of PrEP through pharmacies is one approach utilized in the US to improve accessibility. Retail pharmacies are commonly used as a first-line access point for medical care in Kenya, but have not been utilized for PrEP delivery. We conducted a collaborative consultative meeting of stakeholders to develop a care pathway for pharmacy-based PrEP delivery in Kenya.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In January 2020, we held a one-day meeting in Nairobi with 36 stakeholders from PrEP regulatory, professional, healthcare service delivery, civil society, and research organizations. Attendees reviewed a theory of change model, results from formative qualitative research with pharmacy providers and clients, and anticipated core components of pharmacy-based PrEP delivery: counseling, HIV testing, prescribing, and dispensing. Stakeholders participated in small and large group discussions to identify potential challenges and solutions. We synthesized the key findings from these discussions.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Stakeholders were enthusiastic about a model for pharmacy-based PrEP delivery. Potential challenges identified included insufficient pharmacy provider knowledge and skills, regulatory hurdles to providing affordable HIV testing at pharmacies, and undefined pathways for PrEP procurement. Potential solutions identified included having pharmacy providers complete the Kenya Ministry of Health-approved PrEP training, use of a PrEP prescribing checklist with remote clinician oversight and provider-assisted HIV self-testing, and having the government provide PrEP and HIV self-testing kits to pharmacies during a pilot test. A care pathway was developed over the course of the meeting.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>PrEP delivery stakeholders in Kenya were strongly supportive of developing and testing a model for pharmacy-based PrEP delivery to increase PrEP access. We collaboratively developed a care pathway for pilot testing that has the potential to expand PrEP delivery options in Kenya and other similar settings.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12913-020-05898-9","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T03:02:22Z","timestamp":1605150142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation"],"prefix":"10.1186","volume":"20","author":[{"name":"on Behalf of Stakeholders for Pharmacy-based PrEP Delivery in Kenya Consultation","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5675-8836","authenticated-orcid":false,"given":"Katrina F.","family":"Ortblad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mogere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kamolloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Odoyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Irungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly R.","family":"Mugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Pintye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared M.","family":"Baeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bukusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ngure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"5898_CR1","volume-title":"Communities at the centre: defending rights, breaking barriers, reaching people with HIV services","author":"UNAIDS","year":"2019","unstructured":"UNAIDS. Communities at the centre: defending rights, breaking barriers, reaching people with HIV services. Geneva: UNAIDS; 2019. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2019-global-AIDS-update_en.pdf. Cited 2020 Apr 17."},{"key":"5898_CR2","volume-title":"Kenya AIDS response progress report 2018","author":"Kenya Ministry of Health","year":"2018","unstructured":"Kenya Ministry of Health. Kenya AIDS response progress report 2018. Nairobi: National AIDS Control Council; 2018. Available from: https:\/\/www.lvcthealth.org\/wp-content\/uploads\/2018\/11\/KARPR-Report_2018.pdf. Cited 2020 May 4."},{"issue":"27","key":"5898_CR3","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30;363(27):2587\u201399.","journal-title":"N Engl J Med"},{"issue":"5","key":"5898_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012 Aug 2;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"issue":"5","key":"5898_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012 Aug 2;367(5):423\u201334.","journal-title":"N Engl J Med"},{"issue":"9883","key":"5898_CR6","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013 Jun 15;381(9883):2083\u201390.","journal-title":"Lancet."},{"issue":"2","key":"5898_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11904-019-00437-6","volume":"16","author":"G O\u2019Malley","year":"2019","unstructured":"O\u2019Malley G, Barnabee G, Mugwanya K. Scaling-up PrEP delivery in sub-Saharan Africa: what can we learn from the scale-up of ART? Curr HIV\/AIDS Rep. 2019;16(2):141\u201350.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"8","key":"5898_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002099","volume":"13","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, et al. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1-serodiscordant couples: a prospective implementation study in Kenya and Uganda. PLoS Med. 2016 Aug;13(8):e1002099.","journal-title":"PLoS Med"},{"key":"5898_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/1472-6963-14-231","volume":"14","author":"N Mack","year":"2014","unstructured":"Mack N, Odhiambo J, Wong CM, Agot K. Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: Results of a consultation with community stakeholders. BMC Health Serv Res. 2014;14:231.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"5898_CR10","doi-asserted-by":"publisher","first-page":"21134","DOI":"10.7448\/IAS.19.1.21134","volume":"19","author":"RC Patel","year":"2016","unstructured":"Patel RC, Stanford-Moore G, Odoyo J, Pyra M, Wakhungu I, Anand K, et al. \u201cSince both of us are using antiretrovirals, we have been supportive to each other\u201d: facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya. J Int AIDS Soc. 2016;19(1):21134.","journal-title":"J Int AIDS Soc"},{"issue":"11","key":"5898_CR11","doi-asserted-by":"publisher","first-page":"e967","DOI":"10.1016\/j.ijid.2010.05.016","volume":"14","author":"G Bigogo","year":"2010","unstructured":"Bigogo G, Audi A, Aura B, Aol G, Breiman RF, Feikin DR. Health-seeking patterns among participants of population-based morbidity surveillance in rural western Kenya: implications for calculating disease rates. Int J Infect Dis. 2010 Nov;14(11):e967\u201373.","journal-title":"Int J Infect Dis"},{"key":"5898_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1475-2875-6-57","volume":"6","author":"W Mutemi","year":"2007","unstructured":"Abuya TO, Mutemi W, Karisa B, Ochola SA, Fegan G, Marsh V. Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions. Malar J. 2007 May 10;6:57.","journal-title":"Malar J"},{"issue":"1","key":"5898_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s12913-018-3343-z","volume":"18","author":"C Mayora","year":"2018","unstructured":"Mayora C, Kitutu FE, Kandala N-B, Ekirapa-Kiracho E, Peterson SS, Wamani H. Private retail drug shops: what they are, how they operate, and implications for health care delivery in rural Uganda. BMC Health Serv Res. 2018;18(1):532.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"5898_CR14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.9745\/GHSP-D-16-00197","volume":"4","author":"M Corroon","year":"2016","unstructured":"Corroon M, Kebede E, Spektor G, Speizer I. Key role of drug shops and pharmacies for family planning in urban Nigeria and Kenya. Glob Health Sci Pract. 2016;4(4):594\u2013609.","journal-title":"Glob Health Sci Pract"},{"issue":"1","key":"5898_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12936-017-1997-3","volume":"16","author":"J Ladner","year":"2017","unstructured":"Ladner J, Davis B, Audureau E, Saba J. Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries. Malar J. 2017 Aug 29;16(1):353.","journal-title":"Malar J"},{"issue":"4","key":"5898_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/sextrans-2014-051751","volume":"91","author":"PM Mugo","year":"2015","unstructured":"Mugo PM, Prins HAB, Wahome EW, Mwashigadi GM, Thiong\u2019o AN, Gichuru E, et al. Engaging young adult clients of community pharmacies for HIV screening in coastal Kenya: a cross-sectional study. Sex Transm Infect. 2015 Jun;91(4):257\u20139.","journal-title":"Sex Transm Infect"},{"issue":"8","key":"5898_CR17","first-page":"689","volume":"24","author":"UA Igun","year":"1987","unstructured":"Igun UA. Why we seek treatment here: retail pharmacy and clinical practice in Maiduguri, Nigeria. Soc Sci Med 1982. 1987;24(8):689\u201395.","journal-title":"Soc Sci Med 1982"},{"issue":"1","key":"5898_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11096-005-4801-3","volume":"29","author":"N Viberg","year":"2007","unstructured":"Viberg N, Tomson G, Mujinja P, Lundborg CS. The role of the pharmacist-voices from nine African countries. Pharm World Sci PWS. 2007;29(1):25\u201333.","journal-title":"Pharm World Sci PWS"},{"key":"5898_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1472-6963-12-223","volume":"12","author":"FN Wafula","year":"2012","unstructured":"Wafula FN, Miriti EM, Goodman CA. Examining characteristics, knowledge and regulatory practices of specialized drug shops in sub-Saharan Africa: a systematic review of the literature. BMC Health Serv Res. 2012 Jul 27;12:223.","journal-title":"BMC Health Serv Res"},{"key":"5898_CR20","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection - Second edition","author":"WHO","year":"2016","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection - Second edition. Geneva: WHO; 2016."},{"key":"5898_CR21","volume-title":"Guidelines on the use of antiretroviral drugs for treating and preventing HIV infection in Kenya - 2018 edition","author":"Kenya Ministry of Health","year":"2018","unstructured":"Kenya Ministry of Health. Guidelines on the use of antiretroviral drugs for treating and preventing HIV infection in Kenya - 2018 edition. Nairobi: Kenya Ministry of Health; 2018. Available from: http:\/\/cquin.icap.columbia.edu\/wp-content\/uploads\/2017\/04\/ICAP_CQUIN_Kenya-ARV-Guidelines-2018-Final_20thAug2018.pdf. Cited 2020 Apr 22."},{"issue":"6","key":"5898_CR22","first-page":"456","volume":"70","author":"D Aywak","year":"2017","unstructured":"Aywak D, Jaguga CDP, Nkonge NG, Kinuthia R, Ambale C, Awle IA. Pharmacy practice in Kenya. Can J Hosp Pharm. 2017;70(6):456\u201362.","journal-title":"Can J Hosp Pharm"},{"issue":"1","key":"5898_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170868","volume":"12","author":"PM Mugo","year":"2017","unstructured":"Mugo PM, Micheni M, Shangala J, Hussein MH, Graham SM, de Wit TFR, et al. Uptake and acceptability of oral HIV self-testing among community pharmacy clients in Kenya: a feasibility study. PLoS One. 2017 Jan 26;12(1):e0170868.","journal-title":"PLoS One"},{"issue":"6","key":"5898_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1071\/SH18084","volume":"15","author":"EL Tung","year":"2018","unstructured":"Tung EL, Thomas A, Eichner A, Shalit P. Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care. Sex Health. 2018 Nov;15(6):556\u201361.","journal-title":"Sex Health"},{"key":"5898_CR25","volume-title":"One-step PrEP","author":"Kelley-Ross Pharmacy Group","year":"2020","unstructured":"Kelley-Ross Pharmacy Group. One-step PrEP. 2020. Available from: https:\/\/www.kelley-ross.com\/polyclinic\/prep\/."},{"key":"5898_CR26","volume-title":"Framework for the implementation of pre-exposure prophylaxis of HIV in Kenya","author":"Kenya Ministry of Health","year":"2017","unstructured":"Kenya Ministry of Health. Framework for the implementation of pre-exposure prophylaxis of HIV in Kenya. Nairobi: National AIDS & STI Control Programme (NASCOP), Kenya Ministry of Health; 2017. Available from: https:\/\/www.prepwatch.org\/wp-content\/uploads\/2017\/05\/Kenya_PrEP_Implementation_Framework-1.pdf."},{"key":"5898_CR27","volume-title":"Kenya","author":"PrEP Watch","year":"2020","unstructured":"PrEP Watch: Kenya. 2020. Available from: https:\/\/www.prepwatch.org\/country\/kenya\/."},{"key":"5898_CR28","unstructured":"Mugambi M. NASCOP status updates: HTS\/PrEP. Pharmacy PrEP Stakeholders Meeting. Nairobi; 2020."},{"key":"5898_CR29","unstructured":"Pharmacy and Poisons Board. License Status: Pharmacy and Poisons Board. Available from: https:\/\/practice.pharmacyboardkenya.org\/LicenseStatus. Cited 2020 May 20."},{"key":"5898_CR30","volume-title":"National launch of PrEP and HIV self-testing guidelines","author":"Centre for Health Solutions - Kenya","year":"2017","unstructured":"Centre for Health Solutions - Kenya. National launch of PrEP and HIV self-testing guidelines. 2017. Available from: https:\/\/www.chskenya.org\/media_centre\/national-launch-prep-hiv-self-testing-guidelines\/. Cited 2020 Apr 21."},{"key":"5898_CR31","volume-title":"The Kenya HIV testing services guidelines","author":"Kenya Ministry of Health","year":"2015","unstructured":"Kenya Ministry of Health. The Kenya HIV testing services guidelines. Nairobi: Kenyan Ministry of Health; 2015. Available from: https:\/\/aidsfree.usaid.gov\/sites\/default\/files\/hts_policy_kenya_2015.pdf. Cited 2017 Aug 20."},{"key":"5898_CR32","unstructured":"Irungu E, Ngure K, Mugwanya K, Mugo N, Bukusi E, Odoyo J, Wamoni W, Morton J, O'Malley, G, Baeten. Surmounting PrEP delivery challenges through adaptation of implementation guidelines: Lessons learned from HIV care clinics in Kenya. IAS 2019: 10th IAS Conference on HIV Science, Mexico City, Mexico, July 21\u201324, 2019. Abstract WEPDC0204."},{"issue":"2","key":"5898_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/QAI.0000000000001575","volume":"77","author":"K Mugwanya","year":"2018","unstructured":"Mugwanya K, Baeten JM, Wyatt C, Mugo NR, Celum C, Ronald A, et al. Frequency of monitoring kidney function in HIV-uninfected persons using daily oral tenofovir disoproxil fumarate pre-exposure prophlyaxis. J Acquir Immune Defic Syndr. 2018;77(2):206\u201311.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05898-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-020-05898-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05898-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T03:02:55Z","timestamp":1605150175000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-020-05898-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5898"],"URL":"https:\/\/doi.org\/10.1186\/s12913-020-05898-9","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"31 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We received ethical approval to conduct formative research, including engagement with stakeholders during a one-day meeting, from institutional review boards at the Kenya Medical Research Institute (KEMRI) and University of Washington (UW). Because stakeholders were involved in the collaborative development of the care pathway and were not research subjects themselves, the need for individual stakeholder consent was waived by the KEMRI and UW institutional review boards. All stakeholders reviewed and approved this manuscript for publication and have been acknowledged for their participation in the care pathway development process.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors of this paper declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1034"}}